Tiziana Life Sciences is trading 14.16% up at $1.10 in pre-market, with no clear company-specific catalyst identified for September 2, 2026.
- The official news page lists no announcements from August 25 through September 2, 2026.
- The latest update, dated August 24, concerned an ALS clinical-trial poster presentation and does not directly explain the move.
- Broader markets are slightly lower, so macro sentiment does not clearly explain the gain.